Research showed that activation of UPR may lead to the suppression of surface expression of MHC class I (MHC-I) molecules, which is mediated by the upregulation of X-box binding protein 1s(XBP1s) and ATF6, ultimately resulting in immune evasion by tumor cells [9]. Here, ATF6 is linked to neoplasm.